<DOC>
	<DOC>NCT01334944</DOC>
	<brief_summary>The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.</brief_summary>
	<brief_title>Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Pain: Patients with baseline Visual Analog Scale assessment &gt;3, and/or Fever: Patients with temperature &gt;101Â°F. 1. Patients with inadequate IV access 2. Patients &lt;18 years of age 3. History or allergy or hypersensitivity to any component of intravenous ibuprofen, aspirin (or aspirin related products) or nonsteroidal antiinflammatory drug (NSAIDs) 4. Active hemorrhage or clinically significant bleeding 5. Pregnant or nursing 6. Patients in the perioperative period in the setting of coronary artery bypass graft (CABG) surgery 7. Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]), and agree to abide by the study restrictions 8. Refusal to provide written authorization for use and disclosure of protected health information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Fever</keyword>
</DOC>